"HIV Antigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antigens associated with specific proteins of the human adult T-cell immunodeficiency virus (HIV); also called HTLV-III-associated and lymphadenopathy-associated virus (LAV) antigens.
| Descriptor ID |
D015488
|
| MeSH Number(s) |
D23.050.327.520
|
| Concept/Terms |
HIV Antigens- HIV Antigens
- Antigens, HIV
- AIDS Antigens
- Antigens, AIDS
- HIV Associated Antigens
- Antigens, HIV Associated
- Associated Antigens, HIV
- HIV-Associated Antigens
- Antigens, HIV-Associated
- HTLV III Antigens
- Antigens, HTLV III
- III Antigens, HTLV
- T Lymphotropic Virus Type III Antigens, Human
- HTLV III LAV Antigens
- HTLV-III-LAV Antigens
- Antigens, HTLV-III-LAV
- LAV Antigens
- Antigens, LAV
- Lymphadenopathy Associated Antigens
- Antigens, Lymphadenopathy Associated
- Associated Antigens, Lymphadenopathy
- Lymphadenopathy-Associated Antigens
- Antigens, Lymphadenopathy-Associated
- T-Lymphotropic Virus Type III Antigens, Human
- HTLV-III Antigens
- Antigens, HTLV-III
|
Below are MeSH descriptors whose meaning is more general than "HIV Antigens".
Below are MeSH descriptors whose meaning is more specific than "HIV Antigens".
This graph shows the total number of publications written about "HIV Antigens" by people in this website by year, and whether "HIV Antigens" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "HIV Antigens" by people in Profiles.
-
Alpha-galactosylceramide is an effective mucosal adjuvant for repeated intranasal or oral delivery of HIV peptide antigens. Vaccine. 2009 May 26; 27(25-26):3335-41.
-
Protection by dendritic cells-based HIV synthetic peptide cocktail vaccine: preclinical studies in the SHIV-rhesus model. Vaccine. 2005 Mar 18; 23(17-18):2154-9.
-
Improving the sensitivity of the ELISPOT analyses of antigen-specific cellular immune responses in rhesus macaques. Methods Mol Biol. 2005; 302:153-66.
-
Dendritic cells enhance detection of antigen-specific cellular immune responses by lymphocytes from rhesus macaques immunized with an HIV envelope peptide cocktail vaccine. J Med Primatol. 2003 Apr; 32(2):67-73.
-
Immunoliposomes containing antibodies to costimulatory molecules as adjuvants for HIV subunit vaccines. AIDS Res Hum Retroviruses. 1998 Mar 20; 14(5):409-17.
-
Cross-reactive cytotoxic T lymphocytes induced by V3 loop synthetic peptides from different strains of human immunodeficiency virus type 1. Virology. 1995 Aug 01; 211(1):261-7.
-
Identification of T-cell epitopes without B-cell activity in the first and second conserved regions of the HIV Env protein. AIDS. 1991 Jun; 5(6):699-707.